COSMA Dementia App entry into Scandinavian Market

随着年龄的增长，越来越多的全球人口出现记忆问题、抑郁、时空定向障碍或逻辑推理能力下降。这些发作症状可能导致早期神经退行性疾病，例如痴呆。随着这些疾病的发展，脑电波活动会下降。目前的药物治疗会带来严重的副作用，而非药物治疗，即大脑训练应用程序并不针对患者，也没有通过临床试验进行验证。我们的目标是通过开发独特的个性化，临床验证的认知应用程序，通过应用治疗游戏和机器来改善患者的认知大脑功能好处：（1）非侵入性;（2）提高心理能力;（3）全球市场;（5）确保患者独立性;（6）减少对医疗保健系统的压力;以及（6）将加强英国在神经系统疾病研究方面的领导地位。

There is an increasing proportion of the global population with memory problems, depression, space-time disorientation or decreased logical reasoning with aging. These onset symptoms may lead to early-stage neurodegenerative disorders e.g. dementia. As these conditions progress, the brainwave activities decline.Present drug treatments come with severe side-effects, and non-drug treatments i.e. brain training apps are not patient specific and are not validated through clinical trials.We aim to address this global issue by developing a unique-personalised, clinically validated cognitive app which improves a patient's cognitive brain function through application of therapeutic games and machine learning.Benefits: (1) non-invasive; (2) improved mental ability; (3) global market; (5) ensures patient independence; (6) reduced stress upon healthcare systems; and (6) will strengthen UK as leader in neurological disorder research.